"Drugmaker Merck has set up an independent committee to review the firm's actions prior to the withdrawal of its painkiller Vioxx from the market in September.
. . .
"Merck has appointed William Bowen, chair of the firm's corporate governance committee, to chair the special committee. " [Guradian UK - Emphasis added]
